Perform Another (Advanced) Search

1.  Study Posting (2246) Trial #158335, Lymphomas, Duarte, CA
...of High Dose Chemotherapy with Autologous Stem Cell Transfusion and a Gemcitabine- or Vinorelbine- or Vinblastine- Containing Treatment Regimen You have been asked to participate in this research study because you ...
...dose chemotherapy with autologous stem cell transplant and further chemotherapy involving gemcitabine or vinorelbine or vinblastine. The purpose of this study is to evaluate how often and for how long Hodgkin ...
View Page

2.  Study Posting (4519) Trial #124921, Renal Cell Cancer, Weiden, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

3.  Study Posting (4519) Trial #123788, Renal Cell Cancer, Stuttgart, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

4.  Study Posting (4519) Trial #126179, Renal Cell Cancer, Rehling, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

5.  Study Posting (4519) Trial #123285, Renal Cell Cancer, Magdeburg, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

6.  Study Posting (4519) Trial #123280, Renal Cell Cancer, Leipzig, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

7.  Study Posting (4519) Trial #123758, Renal Cell Cancer, Kiel, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

8.  Study Posting (4519) Trial #124666, Renal Cell Cancer, Kassel, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

9.  Study Posting (4519) Trial #124202, Renal Cell Cancer, Jena, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

10.  Study Posting (4519) Trial #122505, Renal Cell Cancer, Hannover, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

11.  Study Posting (4519) Trial #123736, Renal Cell Cancer, Halle, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

12.  Study Posting (4519) Trial #125490, Renal Cell Cancer, Frankfurt Am Main, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

13.  Study Posting (4519) Trial #124554, Renal Cell Cancer, Erlangen, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

14.  Study Posting (4519) Trial #123541, Renal Cell Cancer, Dessau, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

15.  Study Posting (4519) Trial #123665, Renal Cell Cancer, Bremen, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

16.  Study Posting (4519) Trial #122495, Renal Cell Cancer, Berlin, Germany
...will assess the efficacy and safety of Avastin in combination with interferon alfa-2a and vinblastine as first line treatment in patients with metastatic renal cell cancer. Patients will receive Avastin ...
...alfa-2a 3 times weekly (3 Mio IU sc escalating to 18 Mio sc) and vinblastine (0.1mg/kg iv) every 3 weeks. The anticipated time on study treatment is until ...
View Page

17.  Study Posting (1918) Trial #158884, Prostate Cancer, Savannah, GA
...since prior chemotherapy (6 weeks for nitrosoureas or mitomycin) and recovered No prior doxorubicin or vinblastine for patients receiving induction chemotherapy with KAVE (ketoconazole, doxorubicin, vinblastine, estramustine) No prior docetaxel for patients receiving induction chemotherapy with prednisone plus docetaxel • Endocrine therapy ...
View Page